The DOI matches its Crossref record; 148 of the 151 references it cites were found in a registry or an index.
Hepatitis C infection, antiviral treatment and mental health: A European expert consensus statement
Abstract
Mental health problems frequently occur in chronic infection with the hepatitis C virus (HCV) and during antiviral treatment with pegylated interferon-alpha (PegIFNα) and ribavirin. Depression is one of the most important complications during antiviral treatment of chronic hepatitis C infection. However, an increased prevalence of depression, fatigue, and cognitive disturbances has also been reported in untreated HCV-positive patients. Patients with psychiatric disorders or drug addiction also have an increased risk of HCV infection. Furthermore, because of possible drug-drug interactions, new antivirals administered together with PegIFNα and ribavirin may complicate psychiatric side effect management, even if no specific psychiatric adverse events are known so far for these new drugs. The European liver patient's organization (ELPA) organised a European expert conference to review the literature and develop expert recommendations for the management of mental health problems in HCV infected patients. This paper results from the output of the 2011 EASL meeting and subsequent dialogue with patient groups and relevant experts in Europe. It summarises the current knowledge of HCV infection and the brain; prevalence, course, and neurobiology of IFN-α associated psychiatric side effects; possible risk factors for IFN-α associated depression and suicide attempts; psychiatric management of HCV infected patients before and during antiviral treatment; prevention of IFN- α associated psychiatric side effects; and psychiatric aspects of the new antivirals. The summarised current knowledge about mental health changes before and during antiviral treatment should improve interdisciplinary management of HCV infected patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Historical data have shown that interferon (INF)based antiviral therapy for patients with HCV is frequently associated with treatment-induced DEP and ANX.[22]”
From Prevalence of depression and anxiety symptoms by liver disease etiology (2023) · cites this paper as [22]
In the citing paper
“Schaefer and colleagues reported the prevalence of DEP during INF treatment to be 30%-70% based on 10 studies, though prevalence rates varied by type of screening instrument.”
From Prevalence of depression and anxiety symptoms by liver disease etiology (2023) · cites this paper as [22]
In the citing paper
“For example, it was estimated that MDD developed in 15%-45% of patients treated with INF, [22] as assessed by diagnostic interview.”
From Prevalence of depression and anxiety symptoms by liver disease etiology (2023) · cites this paper as [22]
Citations
Cites
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
Fried, M. W., Shiffman, M. L., Reddy, K. R., Smith, C. I., Marinos, G., Gonçales, F. L., Häussinger, D., Moisés Diago, M., Carosi, G., Dhumeaux, D., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020047 · Cited by 6,386
Manns, M. P., McHutchison, J. G., Gordon, S. C., Rustgi, V. K., Shiffman, M. L., Reindollar, R., Goodman, Z. D., Koury, K. J., Ling, M.-H., & Albrecht, J. K. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06102-5 · Cited by 6,027
McHutchison, J. G., Gordon, S. C., Schiff, E. R., Shiffman, M. L., Lee, W. M., Rustgi, V. K., Goodman, Z. D., Ling, M.-H., Cort, S., & Albrecht, J. K. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811193392101 · Cited by 3,457
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
Ghany, M. G., Strader, D. B., Thomas, D. L., & Seeff, L. B. (2008) · Hepatology · doi:10.1002/hep.22759 · Cited by 2,986
Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis C
Hadziyannis, S. J., Sette, H., Morgan, T. R., Balan, V., Moisés Diago, M., Marcellin, P., Ramadori, G. P., Bodenheimer, H., Bernstein, D., Rizzetto, M., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-5-200403020-00010 · Cited by 2,835
Boceprevir for Untreated Chronic HCV Genotype 1 Infection
Poordad, F. F., McCone, J., Bacon, B. R., Bruno, S., Manns, M. P., Sulkowski, M., Jacobson, I. M., Reddy, K. R., Goodman, Z. D., Boparai, N., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1010494 · Cited by 2,512
Peginterferon Alfa-2a in Patients with Chronic Hepatitis C
Zeuzem, S., Feinman, S. V., Rasenack, J. W. F., Heathcote, E. J., Lai, M., Gane, E. J., O’Grady, J., Reichen, J., Moisés Diago, M., Lin, A., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012073432301 · Cited by 1,218
Immune system to brain signaling: Neuropsychopharmacological implications
Capuron, L., & Miller, A. H. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.01.014 · Cited by 1,195
Self-citationParoxetine for the prevention of depression induced by high-dose interferon alfa.
Musselman, D. L., Lawson, D. H., Gumnick, J. F., Manatunga, A. K., Penna, S., Goodkin, R. S., Greiner, K., Nemeroff, C. B., & Miller, A. H. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103293441303 · Cited by 1,120
EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
1 (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.02.023 · Cited by 1,080
Flagged first, then by citations
3 of the 151 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Forton, 2008, Cerebral immune activation in chronic hepatitis C infection: a magnetic resonance spectroscopy study, J Hepatol, 49, 316, 10.1016/j.jhep.2008.03.022 · DOI
- Schaefer, 2008, Clinical management of interferon-alfa-associated psychiatric side effects during hepatitis C treatment, Hot Top Viral Hepat, 9, 11
Cited by
Sorted by citations
Items 101–200 of 225
Cozzolongo, R., Porcelli, P., Lanzilotta, E., Giannuzzi, V., & Leandro, G. (2015) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2015.04.010 · Cited by 11
Hepatitis C: clinical and biological features related to different forms of cocaine use
Schuch, S., Scherer, J. N., Kessler, F. H. P., Sordi, A. O., Pechansky, F., & DIEMEN, L. V. (2017) · Trends in Psychiatry and Psychotherapy · doi:10.1590/2237-6089-2016-0076 · Cited by 11
Hepatitis C, mental health and equity of access to antiviral therapy: a systematic narrative review
Hepworth, J., Bain, T., & van Driel, M. (2013) · International Journal for Equity in Health · doi:10.1186/1475-9276-12-92 · Cited by 10
Hahn, D., Stokes, C. S., Kaiser, R., Meyer, M. R., Lammert, F., & Gruenhage, F. (2018) · European Journal of Clinical Investigation · doi:10.1111/eci.13024 · Cited by 10
Prevalence and detection of neuropsychiatric adverse effects during hepatitis C treatment
Masip, M., Tuneu, L., Pagès‐Puigdemont, N., Torras, X., Gallego, A., Guardiola, J. M., Faus, M. J., & Mangues, M. A. (2015) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-015-0177-1 · Cited by 10
Hepatitis C Pretreatment Profile and Gender Differences: Cognition and Disease Severity Effects
Barreira, D. P., Marinho, R. T., Bicho, M., Flores, I., Fialho, R., & Ouakinin, S. (2019) · Frontiers in Psychology · doi:10.3389/fpsyg.2019.02317 · Cited by 10
Stasi, C., Rosselli, M., Zignego, A. L., Laffi, G., & Milani, S. (2013) · Hepatology Research · doi:10.1111/hepr.12116 · Cited by 10
Biopsychosocial predictors of interferon-related depression in patients with Hepatitis C
Murri, M. B., Cecere, A. C., Masotti, M., Sammito, G., la Marca, A., Torres, G. V., Bonfitto, I., Cuozzo, E., Rossi, L., Serviddio, G., et al. (2017) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2017.01.001 · Cited by 9
The role of the Primary Healthcare Network in Iran in hepatitis C virus elimination by 2030
Behzadifar, M., Gorji, H. A., Rezapour, A., Bragazzi, N. L., & Alavian, S. M. (2018) · Journal of Virus Eradication · doi:10.1016/s2055-6640(20)30265-x · Cited by 9
Perceived Stress in Hepatitis C Virus Infected Patients under the DAA-Based Therapy
Danilescu, C. M., Ionescu, M., Săndulescu, L., Pîrlog, M. C., Streba, C. T., & Rogoveanu, I. (2022) · Diagnostics · doi:10.3390/diagnostics12051177 · Cited by 9
Golabi, P., Elsheikh, E. B., Karrar, A., Estep, J. M., Younossi, I. M., Stepanova, M., Gerber, L. H., & Younossi, Z. M. (2016) · Medicine · doi:10.1097/md.0000000000005066 · Cited by 9
Evaluation of cellular responses for a chimeric HBsAg-HCV core DNA vaccine in BALB/c mice
Roohvand, F., Yazdanian, M., Memarnejadian, A., Mahdavi, M., Motevalli, F., Sadat, S. M., Vahabpour, R., Khanahmad, H., Soleimanjahi, H., & Budkowska, A. (2014) · Advanced Biomedical Research · doi:10.4103/2277-9175.148296 · Cited by 9
Kawase, K., Kondo, K., Saito, T., Shimasaki, A., Takahashi, A., Kamatani, Y., Kawabe, N., Hashimoto, S., Ikeda, M., Kubo, M., et al. (2016) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12424 · Cited by 8
Chen, V. C., Lu, M., Yang, Y., Weng, J., & Chang, C. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.04.093 · Cited by 8
Lin, C. Y., Guu, T., Lai, H., Peng, C., Chiang, J. Y.-J., Chen, H., Li, T., Yang, S.-Y., Su, K., & Chang, J. P. (2020) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2019.100035 · Cited by 8
Wedemeyer, H. H., Marco, V. D., Garcı́a-Retortillo, M., Teti, E., Fraser, C., Morano, L. E., Rodríguez‐Tajes, S., Acosta-López, S., O’Loan, J., Milella, M. S., et al. (2022) · Viruses · doi:10.3390/v14112493 · Cited by 8
Genotype 1 of hepatitis C virus increases the risk of major depression: a 12-week prospective study
Bueno, E. C. M. D. C., Behrensdorf, M. F., Bavaresco, V., Zambrano, D. N., Bellini, J., Kaster, M. P., Spessato, B. C., & Ghisleni, G. (2015) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2015.03.016 · Cited by 8
Galicia, N., Díez, P., Dégano, R. M., Guest, P. C., Ibarrola, N., & Fuentes, M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-52479-5_5 · Cited by 8
Nordien, R., Sonderup, M. W., & Spearman, C. W. (2020) · South African Medical Journal · doi:10.7196/samj.2020.v110i2.14208 · Cited by 8
Porcelli, P., Cozzolongo, R., Lanzilotta, E., Giannuzzi, V., & Leandro, G. (2014) · Psychotherapy and Psychosomatics · doi:10.1159/000360821 · Cited by 8
Bassiony, M. M., Yousef, A. M., Youssef, U. M., El-deen, G. M. S., Abdelghani, M., Al-Gohari, H., Fouad, E., & El-Shafaey, M. (2015) · The International Journal of Psychiatry in Medicine · doi:10.1177/0091217415605029 · Cited by 7
Steiner, S., Raguž-Lučić, N., & Erceg, D. (2017) · InTech eBooks · doi:10.5772/intechopen.70788 · Cited by 7
Influence of gender on cytokine induced depression and treatment
Sarkar, S., Kemper, J., Sarkar, R., Brants, L., Friebe, A., Spengler, U., Schläpfer, T. E., Reimer, J., Buggisch, P., Ockenga, J., et al. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.05.087 · Cited by 9
Self-citationPsychische Störungen bei somatischen Krankheiten
Kapfhammer, H. P. (2011) · Springer eBooks · doi:10.1007/978-3-642-03637-8_76 · Cited by 7
Gragnani, L., Lorini, S., Martini, L., Stasi, C., Visentini, M., Petraccia, L., Marello, N., Monti, M., Marri, S., Madia, F., et al. (2021) · Clinical Rheumatology · doi:10.1007/s10067-021-05877-3 · Cited by 7
Prevalence of depression and anxiety symptoms by liver disease etiology
Doyle, T., Schmidt, B., & Scaglione, S. (2023) · Clinical Liver Disease · doi:10.1097/cld.0000000000000068 · Cited by 6
Balta, A. A. Ș., Ignat, M. D., Barbu, R. E., Dumitru, C. N., Radaschin, D. S., Bulza, V., Costin, S. A., Pleșea-Condratovici, C., & Baroiu, L. (2025) · Healthcare · doi:10.3390/healthcare13161953 · Cited by 6
Psychische Störungen bei somatischen Krankheiten
Kapfhammer, H. (2017) · Springer eBooks · doi:10.1007/978-3-662-49295-6_88 · Cited by 6
Vabo, I. L. C., Ferreira, L. E. V. V. D. C., & Fábio Heleno Lima, P. A. C. E. (2016) · Arquivos de Gastroenterologia · doi:10.1590/s0004-28032016000100005 · Cited by 6
Mental Illness in Adults With HIV and HCV Infection: Indian Health Service, 2001–2020
Smith, C. M., Kennedy, J. L., Evans, M. E., Person, M. K., Haverkate, R., & Apostolou, A. (2022) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2022.03.023 · Cited by 6
Fábregas, B. C., Vieira, É. L. M., Moura, A. S., Carmo, R. A., de Ávila, R. E., Abreu, M. N. S., Prossin, A. R., & Teixeira, A. L. (2016) · NeuroImmunoModulation · doi:10.1159/000444531 · Cited by 6
Wang, L., Chen, S., Chen, C., Yen, C., Chang, J.-J., Lee, T.-S., Liu, C., Chen, L., & Chien, R. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-1135-8 · Cited by 6
Depression, Anxiety and Stress in Egyptian Patients with Chronic Liver Diseases
AbdAllah, A., & Sharafeddin, M. (2020) · The Egyptian Family Medicine Journal/The Egyptian Family Medicine Journal · doi:10.21608/efmj.2020.90200 · Cited by 6
Comparative safety review of the current therapies for gastroenteropancreatic neuroendocrine tumors
Koffas, A., & Toumpanakis, C. (2020) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2021.1867097 · Cited by 6
Qin, Z., Shen, Y., Wu, Y., Tang, H., & Zhang, L. (2021) · Brain and Behavior · doi:10.1002/brb3.2406 · Cited by 6
Bassiony, M. M., Yousef, A. M., Raya, Y., El-Shabrawi, A., Fouad, E. A., & El-Shafeey, M. (2015) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2015.1064964 · Cited by 6
Boglione, L., Lupia, T., Cariti, G., & Perri, G. D. (2019) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2019.06.004 · Cited by 6
Psychiatric Adverse Effects Of Interferon Therapy.
Coman, H. G., Herta, D. C., & Nemeş, B. (2013) · Europe PMC (PubMed Central) · Cited by 6
Cognitive dysfunction: an important extrahepatic manifestation of hepatitis C infection?
Kennelly, S. (2013) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2012-131337 · Cited by 6
Identification of novel human kinases that suppress hepatitis C virus infection
Lee, A., Liu, S., & Wang, T. (2013) · Journal of Viral Hepatitis · doi:10.1111/jvh.12203 · Cited by 5
Michel, L., Lions, C., Winnock, M., Lang, J.-M., Loko, M., Rosenthal, É., Marchou, B., Valantin, M. A., Morlat, P., Roux, P., et al. (2016) · HIV Medicine · doi:10.1111/hiv.12382 · Cited by 5
Farinha‐Ferreira, M., Magalhães, D. M., Neuparth‐Sottomayor, M., Rafael, H., Miranda‐Lourenço, C., & Sebastião, A. M. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16083 · Cited by 5
The Perseo Group, Marco, A., Antón, J. J., Trujols, J., de la Hoya, P. S., de Juan, J., Faraco, I., & Caylà, J. A. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-1102-x · Cited by 5
Hepatitis C Virus Infection Treatment: Recent Advances and New Paradigms in the Treatment Strategies
Shahid, I., Almalki, W. H., Al-Rabia, M. W., Hafeez, M. H., & Ahmed, M. (2017) · InTech eBooks · doi:10.5772/65873 · Cited by 5
Lin, M., Chung, C., Lin, W., Wei, K., Wang, J., Lee, Y.-Y., Hu, J., Tung, T., & Lin, Y. (2017) · Antiviral Therapy · doi:10.3851/imp3172 · Cited by 5
Golfieri, L., Gitto, S., Morelli, M. C., Pinna, A. D., Grandi, S., & Andreoné, P. (2017) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2017.1362334 · Cited by 5
Silbernagl, M., Slamanig, R., Fischer, G., & Brandt, L. (2018) · Health Policy · doi:10.1016/j.healthpol.2018.10.005 · Cited by 6
Cognitive Improvement After HCV Eradication: Extending the Benefits
Bajaj, J. S., & Forton, D. M. (2013) · Hepatology · doi:10.1002/hep.26481 · Cited by 5
Self-citationRoncero, C., Buch-Vicente, B., Martín-Sánchez, Á. M., Álvarez-Navares, A. I., Andrés-Olivera, P., Gamonal-Limcaoco, S., Lozano-López, M. T., Aguilar, L., Sánchez-Casado, F., & García-Ullán, L. (2023) · Gastroenterología y Hepatología (English Edition) · doi:10.1016/j.gastre.2022.06.005 · Cited by 4
Depression trends in Hepatitis-C PCR positive and PCR negative patients
Khuhro, Q., Shaikh, H., Washdev, & Hashmi, S. (2021) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.38.1.4788 · Cited by 4
Lee, D. U., Ponder, R. D., Lee, K. J., Yoo, A., Fan, G. H., Jung, D., Chou, H., Lee, K., Hofheinz, O., & Urrunaga, N. H. (2022) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002498 · Cited by 4
Li, G., Hu, L., Gu, X., Zhu, W., Zhen, X., & Sun, X. (2024) · Neurochemical Research · doi:10.1007/s11064-024-04111-1 · Cited by 4
Lai, Q., Li, W., He, X., Wang, H., He, Q., Hao, C., & Deng, Z. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.05.023 · Cited by 4
Lee, H., Kennedy, C. J., Tu, A., Restivo, J. L., Liu, C. H., Naslund, J. A., Patel, V., Choi, K. W., & Smoller, J. W. (2024) · PLoS ONE · doi:10.1371/journal.pone.0303079 · Cited by 4
Fialho, R., Pereira, M., Gilleece, Y. C., Rusted, J. M., & Whale, R. (2018) · Women & Health · doi:10.1080/03630242.2018.1449778 · Cited by 5
Role of behavioral health providers in treating hepatitis C.
Cos, T. A., Bartholomew, T. S., & Huynh, K. (2019) · Professional Psychology Research and Practice · doi:10.1037/pro0000243 · Cited by 4
Chronic hepatitis C, depression and gender: a state of art
Martín‐Santos, R., Egmond, E., Cavero, M., Mariñó, Z., Subirà, S., Navinés, R., Forns, X., & Valdes, M. (2015) · Advances in Dual Diagnosis · doi:10.1108/add-05-2015-0009 · Cited by 4
Neurocognitive Impairments and Depression and Their Relationship to Hepatitis C Virus Infection
Stănculete, M. F. (2018) · InTech eBooks · doi:10.5772/intechopen.74054 · Cited by 4
Chang, S., Hung, C., Li, S.-F., Lee, H.-M., Chung, Y., Pai, L., & Yang, S. (2013) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2013.08.011 · Cited by 3
Rowan, P. J. (2015) · World Journal of Virology · doi:10.5501/wjv.v4.i1.13 · Cited by 3
Calidad de vida en los pacientes con hepatitis C. Importancia del tratamiento
Mallolas, J., Ahumada, A., Ampuero, J., Blanco, J. R., Hidalgo‐Vega, Á., Londoño, M., Molina, E., & Ruiz, S. (2019) · Gastroenterología y Hepatología · doi:10.1016/s0210-5705(20)30184-9 · Cited by 3
Rafique, S., Khan, M. S., Unar, R., Wajid, M., Waheed, A., & Umar, A. (2021) · Egyptian Liver Journal · doi:10.1186/s43066-021-00120-9 · Cited by 3
Gutiérrez-Rojas, L., Martín, J. J. D. L. G., Buey, L. G., Otano, J. I. U., Mena, Á., & Roncero, C. (2023) · Gastroenterología y Hepatología (English Edition) · doi:10.1016/j.gastre.2022.06.009 · Cited by 3
Hassany, S. M., Darweesh, A. E. D. M., Khalifa, H., Ahmed, G. K., Ramadan, H. K., & Moustafa, E. F. A. (2017) · International Journal of Current Microbiology and Applied Sciences · doi:10.20546/ijcmas.2017.610.059 · Cited by 3
Nava, F. A., Alberti, A., Andreoni, M., Babudieri, S., Barbarini, G., D’Egidio, P. F., Leonardi, C., & Lucchini, A. (2018) · MISSION · doi:10.3280/mis49-2018oa5655 · Cited by 3
Fábregas, B. C., Moura, A. S., de Ávila, R. E., Carmo, R. A., & Teixeira, A. L. (2014) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2013-1210 · Cited by 3
Chiu, W., Lu, M., & Chang, C. (2020) · Psychiatry Investigation · doi:10.30773/pi.2019.0254 · Cited by 3
L’hépatite C dans les établissements pénitentiaires français
Ségéral, O., & Hagège, M. (2013) · Soins · doi:10.1016/j.soin.2013.09.013 · Cited by 2
Okano, H., Takenaka, T., Asakawa, H., Tsuruga, S., Kumazawa, H., Isono, Y., Tanaka, H., Matsusaki, S., Sase, T., Saito, T., et al. (2023) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2023.12100 · Cited by 2
Clark, P. J., Valery, P. C., Strasser, S. I., Weltman, M., Thompson, A., Levy, M. T., Leggett, B., Zekry, A., Rong, J., Sinclair, M. J., et al. (2023) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16440 · Cited by 2
Maternal separation alters peripheral immune responses associated with IFN-γ and OT in mice
Zhang, Y., Chen, H., Cao, J., Gao, L., & Yu, J. (2024) · Peptides · doi:10.1016/j.peptides.2024.171318 · Cited by 3
da Cunha, L. R., Castro, M., DUARTE, G. S., NASCIMENTO, G. C. E., Rocha, G. A., & Silva, L. D. (2021) · Arquivos de Gastroenterologia · doi:10.1590/s0004-2803.202100000-86 · Cited by 2
Pino-Marín, D. E., Giraldo, N. A., & Amariles, P. (2017) · Revista Colombiana de Gastroenterología · doi:10.22516/25007440.81 · Cited by 2
Abou-Hashem, R. M., Shaat, M. M., Hamza, S. A., Mahmoud, N. H., & Ali, S. M. (2020) · Electronic Journal of General Medicine · doi:10.29333/ejgm/7887 · Cited by 2
Psychische Störungen bei somatischen Krankheiten
Kapfhammer, H. (2015) · Springer eBooks · doi:10.1007/978-3-642-45028-0_88-1 · Cited by 2
Semmo, N., Müllhaupt, B., Ruckstuhl, L., Magenta, L., Clerc, O., Torgler, R., & Semela, D. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241267 · Cited by 2
Yang, G., Zhang, S., Wang, Y., Han, B., & Sun, D. (2025) · BMC Public Health · doi:10.1186/s12889-025-24346-z · Cited by 1
Shiner, B. R., Watts, B. V., Rozema, L. R., & Gradus, J. L. (2025) · Clinical Therapeutics · doi:10.1016/j.clinthera.2025.09.008 · Cited by 1
Kageyama, K., Sato, M., Ito, S., Ino, Y., Nakao, S., Bunchuailua, W., Rungpragayphan, S., Krichanchai, S., Iguchi, K., Ishiguro, M., et al. (2026) · Psychiatry Research Communications · doi:10.1016/j.psycom.2026.100250 · Cited by 1
Ding, D. G., Chen, T., Sheng, Y., Lin, J. S. H., & Yuan, Y. (2026) · BMC Public Health · doi:10.1186/s12889-026-28311-2 · Cited by 1
PRE - TREATMENT ANXIETY AND INTERFERON INDUCED DEPRESSION IN HEPATITIS C PATIENTS
Andleeb, S., Jahangir, F., & Shaheen, N. (2016) · Journal of Postgraduate Medical Institute · Cited by 1
Comparative Prevalence Studies of Hepatitis C Patients in Developing Vs Developed Countries
Tahir, U., Ain, Q. U., Waqas, R., & Bashir, I. (2016) · International Current Pharmaceutical Journal · doi:10.3329/icpj.v5i12.30412 · Cited by 1
Malaguarnera, G., Bertino, G., Greco, C., Gagliano, C., Motta, M., Chisari, G., Rapisarda, V., Nunnari, G., Vecchio, M. M., Drago, F., et al. (2017) · Translational Medicine Communications · doi:10.1186/s41231-016-0010-4 · Cited by 1
Wang, L., Chen, S. W., Chien, R., Yen, C., Chang, J. J., Lee, T. S., Liu, C. J., Chen, L. W., & Chen, C. K. (2017) · Neuropsychiatry · doi:10.4172/neuropsychiatry.1000185 · Cited by 1
Manie induite par l’interféron alpha chez un patient atteint d’une hépatite virale B aiguë
Oueslati, B., MOULA, O., Jelalia, I., Tounsi, A., Triki, R., & GHACHEM, R. (2018) · La Presse Médicale · doi:10.1016/j.lpm.2018.02.006 · Cited by 1
Hu, J. H., Chang, M., Liu, N., Yeh, C., & Huang, T. (2021) · Hepatitis Monthly · doi:10.5812/hepatmon.107606 · Cited by 1
Doffoël, M., Ernwein, F., Chaffraix, F., Tripon, S., Lang, J.-P., Lang, A., Haumesser, L., Bader, R., Paya, D., Royant, M., et al. (2021) · Open Journal of Gastroenterology and Hepatology · doi:10.28933/ojgh-2021-10-1205 · Cited by 1
Visconti, M. F., Campanini, M., Fontanella, A., Nardi, R., & Uomo, G. (2016) · Italian Journal of Medicine · doi:10.4081/itjm.q.2016.1 · Cited by 1
Inflammation, Monoclonal Antibodies and Depression: Joining the Dots
Hunt, D. P. J. (2019) · Drug Safety · doi:10.1007/s40264-019-00819-0 · Cited by 1
Nistal‐Villán, E., Argemí, J., Jaime-Soguero, A. D., Ferrero, R., Scala, M. D., Rodríguez‐García, E., Coll, A., Rius‐Rocabert, S., Prìeto, J., González‐Aseguinolaza, G., et al. (2020) · Human Gene Therapy · doi:10.1089/hum.2019.336 · Cited by 1
Nagi, M. L. F., Manan, S., Shaheen, A., Amjad, M., Farooq, M., & Kazmi, S. T. H. (2018) · The Professional Medical Journal · doi:10.29309/tpmj/18.4824 · Cited by 1
Role of Interferon-Gamma and Leucine-Rich Repeat Kinase 2 in Stress-Related Pathology
Litteljohn, D. (2016) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2016-11660
Suicide: An Immunological Disorder?Preprint
O'Connor, K. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3783063 · Cited by 1
Brants, L. (2015) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-16010
Hepatitis C virus infection in patients receiving opiate substitution therapy in Sweden.
Jerkeman, A. (2014) · Lund University Publications (Lund University)
Development of Different Psychiatric Manifestations during Antiviral Therapy for Chronic Hepatitis C
Simonetti, G. (2014) · Journal of Case Reports · doi:10.17659/01.2014.0033
Use of alternative product in patients with chronic viral hepatitis
Dulger, M. (2014) · Journal of Microbiology and Infectious Diseases · doi:10.5799/ahinjs.02.2014.03.0148
Therapiebedingte Depressionen bei malignen Erkrankungen
Schäfer, M. K.-H., & Sarkar, S. (2014) · NeuroTransmitter · doi:10.1007/s15016-014-0876-1
Pino-Marín, D. E., Giraldo, N. A., & Amariles, P. (2016)
Metadata
- Authors
- Schaefer, M., Capuron, L., Friebe, A., Diez-Quevedo, C., Robaeys, G., Neri, S., Foster, G. R., Kautz, A., Forton, D., & Pariante, C. M.
- Affiliations
- Kliniken Essen-Mitte (DE)
- Université de Bordeaux (FR)
- Ruhr University Bochum (DE)
- Ziekenhuis Oost-Limburg (BE)
- University of Catania (IT)
- Queen Mary University of London (GB)
- University of London (GB)
- King's College London (GB)
- Corresponding author
- Schaefer, Martin
- ORCID
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2012-12
- Volume
- 57
- Issue
- 6
- Pages
- 1379-1390
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2153538902
- Cited by
- 225
- References
- 151
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 9 · 2023: 6 · 2022: 11 · 2021: 16 · 2020: 16 · 2019: 13 · 2018: 20 · 2017: 22 · 2016: 26 · 2015: 20 · 2014: 26 · 2013: 24 · 2012: 2
- FWCI
- 14.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Hepatology (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- European Association for the Study of the Liver
- Topics
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Social Sciences › Psychology › Clinical Psychology › COVID-19 and Mental Health
- Keywords
- hepatitis C, chronic hepatitis C, depression, psychiatric adverse effects, pegylated interferon-alpha, ribavirin, antiviral therapy, mental health, fatigue, cognitive disorders, drug addiction, suicide risk, drug-drug interactions, psychiatric management
- MeSH terms
- Antiviral Agents, Depression, Drug Interactions, Hepatitis C, Humans, Mental Health, Risk Factors, Suicide, Attempted, Interferon-alpha
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
